DENTSPLY SIRONA Debt to Equity Ratio 2012-2026 | XRAY
Current and historical debt to equity ratio values for DENTSPLY SIRONA (XRAY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. DENTSPLY SIRONA debt/equity for the three months ending March 31, 2026 was 1.50.
| DENTSPLY SIRONA Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $3.91B | $1.32B | 2.96 |
| 2025-12-31 | $4.09B | $1.34B | 3.05 |
| 2025-09-30 | $4.18B | $1.48B | 2.83 |
| 2025-06-30 | $4.11B | $1.96B | 2.10 |
| 2025-03-31 | $4.04B | $2.01B | 2.01 |
| 2024-12-31 | $3.81B | $1.94B | 1.96 |
| 2024-09-30 | $4.14B | $2.49B | 1.66 |
| 2024-06-30 | $3.83B | $3.06B | 1.25 |
| 2024-03-31 | $3.87B | $3.26B | 1.19 |
| 2023-12-31 | $4.08B | $3.29B | 1.24 |
| 2023-09-30 | $3.83B | $3.37B | 1.14 |
| 2023-06-30 | $3.95B | $3.70B | 1.07 |
| 2023-03-31 | $4.04B | $3.64B | 1.11 |
| 2022-12-31 | $3.83B | $3.81B | 1.01 |
| 2022-09-30 | $3.91B | $3.61B | 1.08 |
| 2022-06-30 | $4.11B | $4.84B | 0.85 |
| 2022-03-31 | $4.31B | $4.86B | 0.89 |
| 2021-12-31 | $4.24B | $5.00B | 0.85 |
| 2021-09-30 | $4.23B | $5.06B | 0.84 |
| 2021-06-30 | $4.30B | $5.08B | 0.85 |
| 2021-03-31 | $4.21B | $4.93B | 0.85 |
| 2020-12-31 | $4.42B | $4.94B | 0.90 |
| 2020-09-30 | $4.13B | $4.76B | 0.87 |
| 2020-06-30 | $3.96B | $4.65B | 0.85 |
| 2020-03-31 | $3.37B | $4.69B | 0.72 |
| 2019-12-31 | $3.51B | $5.10B | 0.69 |
| 2019-09-30 | $3.31B | $5.06B | 0.65 |
| 2019-06-30 | $3.39B | $5.18B | 0.66 |
| 2019-03-31 | $3.50B | $5.11B | 0.68 |
| 2018-12-31 | $3.55B | $5.13B | 0.69 |
| 2018-09-30 | $3.62B | $5.15B | 0.70 |
| 2018-06-30 | $3.68B | $5.14B | 0.72 |
| 2018-03-31 | $3.67B | $6.71B | 0.55 |
| 2017-12-31 | $3.75B | $6.63B | 0.57 |
| 2017-09-30 | $3.71B | $7.49B | 0.50 |
| 2017-06-30 | $3.58B | $7.27B | 0.49 |
| 2017-03-31 | $3.43B | $8.16B | 0.42 |
| 2016-12-31 | $3.43B | $8.13B | 0.42 |
| 2016-09-30 | $3.60B | $8.36B | 0.43 |
| 2016-06-30 | $3.14B | $8.32B | 0.38 |
| 2016-03-31 | $3.30B | $8.39B | 0.39 |
| 2015-12-31 | $2.06B | $2.34B | 0.88 |
| 2015-09-30 | $2.12B | $2.28B | 0.93 |
| 2015-06-30 | $2.18B | $2.32B | 0.94 |
| 2015-03-31 | $2.21B | $2.17B | 1.02 |
| 2014-12-31 | $2.32B | $2.32B | 1.00 |
| 2014-09-30 | $2.39B | $2.50B | 0.96 |
| 2014-06-30 | $2.49B | $2.59B | 0.96 |
| 2014-03-31 | $2.57B | $2.53B | 1.02 |
| 2013-12-31 | $2.50B | $2.58B | 0.97 |
| 2013-09-30 | $2.53B | $2.48B | 1.02 |
| 2013-06-30 | $2.59B | $2.29B | 1.13 |
| 2013-03-31 | $2.63B | $2.27B | 1.16 |
| 2012-12-31 | $2.72B | $2.25B | 1.21 |
| 2012-09-30 | $2.82B | $2.16B | 1.30 |
| 2012-06-30 | $2.88B | $1.99B | 1.45 |
| 2012-03-31 | $2.97B | $2.05B | 1.45 |
| 2011-12-31 | $2.87B | $1.88B | 1.52 |
| 2011-09-30 | $2.94B | $1.89B | 1.56 |
| 2011-06-30 | $1.58B | $2.08B | 0.76 |
| 2011-03-31 | $1.46B | $1.98B | 0.73 |
| 2010-12-31 | $1.35B | $1.91B | 0.71 |
| 2010-09-30 | $1.32B | $1.88B | 0.70 |
| 2010-06-30 | $1.06B | $1.74B | 0.61 |
| 2010-03-31 | $1.10B | $1.88B | 0.59 |
| 2009-12-31 | $1.18B | $1.91B | 0.62 |
| 2009-09-30 | $1.17B | $1.90B | 0.61 |
| 2009-06-30 | $1.09B | $1.80B | 0.61 |
| 2009-03-31 | $1.08B | $1.68B | 0.64 |
| 2008-12-31 | $1.17B | $1.66B | 0.71 |
| 2008-09-30 | $1.08B | $1.59B | 0.68 |
| 2008-06-30 | $1.38B | $1.61B | 0.86 |
| 2008-03-31 | $1.40B | $1.52B | 0.92 |
| 2007-12-31 | $1.16B | $1.52B | 0.77 |
| 2007-09-30 | $1.16B | $1.45B | 0.80 |
| 2007-06-30 | $0.99B | $1.40B | 0.71 |
| 2007-03-31 | $0.96B | $1.34B | 0.72 |
| 2006-12-31 | $0.91B | $1.27B | 0.71 |
| 2006-09-30 | $1.28B | $1.29B | 1.00 |
| 2006-06-30 | $1.32B | $1.25B | 1.05 |
| 2006-03-31 | $1.13B | $1.31B | 0.87 |
| 2005-12-31 | $1.16B | $1.25B | 0.93 |
| 2005-09-30 | $1.21B | $1.26B | 0.96 |
| 2005-06-30 | $1.21B | $1.37B | 0.88 |
| 2005-03-31 | $1.26B | $1.43B | 0.88 |
| 2004-12-31 | $1.35B | $1.44B | 0.94 |
| 2004-09-30 | $1.31B | $1.31B | 0.99 |
| 2004-06-30 | $1.28B | $1.26B | 1.02 |
| 2004-03-31 | $1.30B | $1.21B | 1.07 |
| 2003-12-31 | $1.32B | $1.12B | 1.18 |
| 2003-09-30 | $1.30B | $1.03B | 1.26 |
| 2003-06-30 | $1.33B | $0.98B | 1.36 |
| 2003-03-31 | $1.29B | $0.90B | 1.44 |
| 2002-12-31 | $1.25B | $0.84B | 1.50 |
| 2002-09-30 | $1.24B | $0.75B | 1.65 |
| 2002-06-30 | $1.24B | $0.73B | 1.68 |
| 2002-03-31 | $1.18B | $0.64B | 1.84 |
| 2001-12-31 | $1.19B | $0.61B | 1.95 |
| 2001-09-30 | $0.63B | $0.59B | 1.05 |
| 2001-06-30 | $0.60B | $0.56B | 1.07 |
| 2001-03-31 | $0.54B | $0.54B | 1.01 |
| 2000-12-31 | $0.35B | $0.52B | 0.67 |
| 2000-09-30 | $0.36B | $0.48B | 0.75 |
| 2000-06-30 | $0.37B | $0.48B | 0.77 |
| 2000-03-31 | $0.38B | $0.47B | 0.82 |
| 1999-12-31 | $0.39B | $0.47B | 0.83 |
| 1999-09-30 | $0.43B | $0.46B | 0.94 |
| 1999-06-30 | $0.45B | $0.43B | 1.03 |
| 1999-03-31 | $0.46B | $0.42B | 1.11 |
| 1998-12-31 | $0.48B | $0.41B | 1.16 |
| 1998-09-30 | $0.47B | $0.42B | 1.11 |
| 1998-06-30 | $0.46B | $0.41B | 1.13 |
| 1998-03-31 | $0.36B | $0.44B | 0.82 |
| 1997-12-31 | $0.35B | $0.42B | 0.83 |
| 1997-09-30 | $0.35B | $0.41B | 0.87 |
| 1997-06-30 | $0.35B | $0.39B | 0.90 |
| 1997-03-31 | $0.37B | $0.38B | 0.98 |
| 1996-12-31 | $0.30B | $0.37B | 0.83 |
| 1996-09-30 | $0.32B | $0.35B | 0.90 |
| 1996-06-30 | $0.32B | $0.34B | 0.94 |
| 1996-03-31 | $0.33B | $0.33B | 1.00 |
| 1995-12-31 | $0.28B | $0.32B | 0.89 |
| 1995-09-30 | $0.28B | $0.30B | 0.94 |
| 1995-06-30 | $0.30B | $0.29B | 1.03 |
| 1995-03-31 | $0.22B | $0.28B | 0.78 |
| 1994-12-31 | $0.18B | $0.30B | 0.59 |
| 1994-09-30 | $0.22B | $0.28B | 0.77 |
| 1994-06-30 | $0.23B | $0.27B | 0.87 |
| 1994-03-31 | $0.24B | $0.25B | 0.97 |
| 1993-12-31 | $0.27B | $0.24B | 1.14 |
| 1993-09-30 | $0.00B | 0.00 | |
| 1993-06-30 | $0.38B | $0.12B | 3.12 |
| 1993-03-31 | $0.38B | $0.11B | 3.63 |
| 1992-12-31 | $0.06B | $0.07B | 0.75 |
| 1992-09-30 | $0.00B | 0.00 | |
| 1992-06-30 | $0.00B | 0.00 | |
| 1992-03-31 | $0.00B | 0.00 | |
| 1991-12-31 | $0.04B | $0.06B | 0.64 |
| 1990-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $2.339B | $3.680B |
| DENTSPLY SIRONA Inc. is a global leader in the design, development, manufacture and marketing of dental consumables, dental laboratory products, dental specialty products and consumable medical device products. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. The business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |